Medtech & Diagnostics grants
Non-dilutive capital for devices, diagnostics and digital health
Device and diagnostic companies burn capital long before revenue, which makes federal grants the most efficient money on the table. NIH, NSF and DoD all fund medtech, but each rewards a different story. Clinical need, technical novelty, or operational relevance, choosing the wrong one costs a year.
$240M+ won by our team
PhD-level specialists, never a template or an AI tool.
Agencies funding medtech & diagnostics
- ARPA-H
Programs that fit medtech & diagnostics companies
NIH SBIR/STTR
NIBIB, NCI and NHLBI are the usual homes for device and diagnostic work.
NSF SBIR: Medical Devices
Best fit where the novelty is engineering rather than clinical.
DoD CDMRP & Medical SBIR
Congressionally directed topics with strong device relevance.
What reviewers actually score
- Clear separation of technical risk from regulatory risk
- Bench data that supports the Phase I claim, not just the vision
- Evidence of clinical demand from named users, not market reports
Where we work in medtech & diagnostics
Relevant client wins
Grants our team has won for companies solving comparable technical problems.
Directed Systems
Life sciences: surgical decision support
Grant awarded
NIHR i4i Connect funding secured
Biomedical CatalystLearning with Experts
Life sciences: perinatal AI
Grant awarded
Biomedical Catalyst funding secured
Innovate UK / health fundingPerioperative risk prediction program
Life sciences: clinical risk prediction
≈$410K(£322,500)
£322.5K won, 10m+ patients addressable
Innovate UK grantMediMusic
Life sciences: digital therapeutics
≈$233K(£183,682)
£183,682 for AI-enhanced music therapy
Fund your medtech & diagnostics R&D
Talk to us about your federal funding plans and we'll help you make it happen through effective, results-driven grant writing.